ASO Author Reflections: Is Sentinel Node Biopsy Still of Value for Patients with High-Risk Primary Melanomas Eligible for Adjuvant Immunotherapy?
Saved in:
| Title: | ASO Author Reflections: Is Sentinel Node Biopsy Still of Value for Patients with High-Risk Primary Melanomas Eligible for Adjuvant Immunotherapy? |
|---|---|
| Authors: | Pennington TE; Melanoma Institute Australia, Wollstonecraft, NSW, Australia. pennington_tom@hotmail.com.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. pennington_tom@hotmail.com.; Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia. pennington_tom@hotmail.com., Thompson JF; Melanoma Institute Australia, Wollstonecraft, NSW, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia., Varey AHR; Melanoma Institute Australia, Wollstonecraft, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia.; Department of Plastic and Reconstructive Surgery, Westmead Hospital, Westmead, NSW, Australia. |
| Source: | Annals of surgical oncology [Ann Surg Oncol] 2025 Jun; Vol. 32 (6), pp. 4225-4226. Date of Electronic Publication: 2024 Dec 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1534-4681 |
|---|---|
| DOI: | 10.1245/s10434-024-16821-5 |
